Skip to content
Search

Latest Stories

GPhC announces registration assessment dates

The General Pharmaceutical Council (GPhC) has announced that the provisional registration of pharmacists will be extended to January 2022.

The extension has been made to enable trainee pharmacists from the 2020/21 cohort to apply to join the provisional register once their training is satisfactorily completed.


The pharmacy regulator has also confirmed the dates of the delayed summer and autumn assessments of provisional registrants which will be held from July 27 to 29 and on November 16 respectively.

“The GPhC Council has agreed that provisional registration of pharmacists will be extended to January 2022, to enable trainees from the 2020-21 cohort to apply to join the provisional register once their training is satisfactorily completed, so that they can take up offers of employment at the same time as they usually would, from August 1, 2021,” the regulator said in its latest update.

The extension of provisional registration will make trainees and provisionally registered-pharmacists to wait longer than expected to sit the assessment, join the register, and take up roles as fully-registered pharmacists.

This will also have an impact on employers who would have been expecting newly-qualified pharmacists to join the register from August 2021.

The registration assessment sittings are usually held in June and September. These dates in July and November are the earliest available where Pearson VUE test centres can accommodate the predicted number of candidates under the current social distancing guidelines.

“Candidates on each of the three days will sit a different paper, but we would emphasise that number and types of questions, and the standard required to pass will not change,” the regulator added.

The same eligibility criteria will apply to those planning to join the provisional register in 2021. They will be able to join once they have successfully completed 52 weeks of training (including if they reach 52 weeks after they have sat the registration assessment).

Duncan Rudkin, GPhC Chief Executive, said: “We understand that holding the sittings in July and November will have an impact on pre-registration trainees, provisionally-registered pharmacists and employers. Unfortunately, the pandemic continues to be a significant factor in the logistics of holding assessment sittings and has meant that earlier dates are simply not feasible.

“We regret any challenges this may cause and we hope that extending provisional registration will help mitigate these challenges for trainees and employers. This will also help give potential candidates further options when deciding when they feel fit to sit, depending on their individual circumstances.

“We are committed to learning lessons from feedback from candidates about the forthcoming March assessment and are working with Pearson VUE to improve candidates’ experience of sitting the assessment.”

More For You

Medicine shortages: Penny-pinching costs taxpayers more, warns CCA

Pharmacies are forced to dispense medicines at a loss or face stock shortages.

Getty Images

Government’s penny-pinching approach driving medicine shortages, CCA warns

The Company Chemists’ Association (CCA) has warned the government's longstanding drive to save pennies on the medicines bill is leading to avoidable medicine shortages, ultimately costing taxpayers more.

In a newly released paper, the CCA highlighted how the government has squeezed the price it is willing to pay for many medicines, making the UK a less attractive market for pharmaceutical manufacturers and suppliers.

Keep ReadingShow less
Morrison: Pharmacy contract news

Janet Morrison

Morrison: Pharmacy contract news “before the start of the financial year”


Community pharmacies will get clarity over a new funding contract before the start of the financial year, according to Community Pharmacy England (CPE) chief executive Janet Morrison.

Keep ReadingShow less
Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard, who is set to step down as NHS England chief in April, has been appointed as the next chief executive of Guy’s and St Thomas’ NHS Foundation Trust.

Pritchard previously led the Trust from October 2015 to August 2019 before moving to NHS England, where she later became its first female chief executive in August 2021.

Keep ReadingShow less
Confirm Pharmacy First Funding beyond April- Helen Morgan MP urges health secretary

North Shropshire MP Helen Morgan

Helen Morgan MP calls on Wes Streeting to clarify Pharmacy First’s future

Liberal Democrat health and care spokesperson Helen Morgan has urged the government to provide clarity on the future of Pharmacy First and confirm continued funding beyond April.

In a letter to health secretary Wes Streeting, the North Shropshire MP expressed deep concern over the uncertainty surrounding the initiative, which plays a crucial role in shifting healthcare services into communities.

Keep ReadingShow less
NHS England restructures leadership with new executive team

Except for the deputy chief executive officer, all team members will assume their roles on 1 April 2025.

Getty Images

NHS England announces new executive team to lead transformation

Sir James Mackey will be leading NHS England’s transition into the Department of Health and Social Care (DHSC), along with the incoming team.

He will officially take up the role as the new chief executive officer of NHS England on 1 April 2025, replacing Amanda Pritchard, who is stepping down at the end of this month.

Keep ReadingShow less